Community prevalence and dyad disease pattern of multimorbidity in China and India: a systematic review.
arthritis
epidemiology
hypertension
public health
systematic review
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
22
02
2022
accepted:
18
08
2022
entrez:
16
9
2022
pubmed:
17
9
2022
medline:
21
9
2022
Statut:
ppublish
Résumé
Driven by the increasing life expectancy, China and India, the two most populous countries in the world are experiencing a rising burden of multimorbidity. This study aims to explore community prevalence and dyad patterns of multimorbidity in China and India. We conducted a systematic review of five English and Chinese electronic databases. Studies involving adults 18 years or older at a community level, which reported multimorbidity prevalence and/or patterns were included. A modified Newcastle-Ottawa Scale was used for quality assessment. Despite large heterogeneity among reported studies, a systematic synthesis of the results was conducted to report the findings. From 13 996 studies retrieved, 59 studies met the inclusion criteria (46 in China, 9 in India and 4 in both). The median prevalence of multimorbidity was 30.7% (IQR 17.1, 49.4), ranging from 1.5% to 90.5%. There was a large difference in multimorbidity prevalence between China and India, with median prevalence being 36.1% (IQR 19.6, 48.8) and 28.3% (IQR 8.9, 56.8), respectively. Among 27 studies that reported age-specific prevalence, 19 studies found multimorbidity prevalence increased with age, while 8 studies observed a paradoxical reduction in the oldest age group. Of the 34 studies that reported sex-specific prevalence, 86% (n=32) observed a higher prevalence in females. The most common multimorbidity patterns from 14 studies included hypertensive diseases combined with diabetes mellitus, arthropathies, heart diseases and metabolic disorders. All included studies were rated as fair or poor quality. Multimorbidity is highly prevalent in China and India with hypertensive diseases and other comorbidities being the most observed patterns. The overall quality of the studies was low and there was a lack of representative samples in most studies. Large epidemiology studies, using a common definition of multimorbidity and national representative samples, with sex disaggregation are needed in both countries. CRD42020176774.
Sections du résumé
BACKGROUND
Driven by the increasing life expectancy, China and India, the two most populous countries in the world are experiencing a rising burden of multimorbidity. This study aims to explore community prevalence and dyad patterns of multimorbidity in China and India.
METHODS
We conducted a systematic review of five English and Chinese electronic databases. Studies involving adults 18 years or older at a community level, which reported multimorbidity prevalence and/or patterns were included. A modified Newcastle-Ottawa Scale was used for quality assessment. Despite large heterogeneity among reported studies, a systematic synthesis of the results was conducted to report the findings.
RESULTS
From 13 996 studies retrieved, 59 studies met the inclusion criteria (46 in China, 9 in India and 4 in both). The median prevalence of multimorbidity was 30.7% (IQR 17.1, 49.4), ranging from 1.5% to 90.5%. There was a large difference in multimorbidity prevalence between China and India, with median prevalence being 36.1% (IQR 19.6, 48.8) and 28.3% (IQR 8.9, 56.8), respectively. Among 27 studies that reported age-specific prevalence, 19 studies found multimorbidity prevalence increased with age, while 8 studies observed a paradoxical reduction in the oldest age group. Of the 34 studies that reported sex-specific prevalence, 86% (n=32) observed a higher prevalence in females. The most common multimorbidity patterns from 14 studies included hypertensive diseases combined with diabetes mellitus, arthropathies, heart diseases and metabolic disorders. All included studies were rated as fair or poor quality.
CONCLUSION
Multimorbidity is highly prevalent in China and India with hypertensive diseases and other comorbidities being the most observed patterns. The overall quality of the studies was low and there was a lack of representative samples in most studies. Large epidemiology studies, using a common definition of multimorbidity and national representative samples, with sex disaggregation are needed in both countries.
PROSPERO REGISTRATION NUMBER
CRD42020176774.
Identifiants
pubmed: 36113890
pii: bmjgh-2022-008880
doi: 10.1136/bmjgh-2022-008880
pmc: PMC9486196
pii:
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
BMJ Open. 2017 May 9;7(5):e013548
pubmed: 28490550
Circulation. 2018 May 29;137(22):2344-2356
pubmed: 29449338
Arch Gerontol Geriatr. 2011 May-Jun;52(3):e210-4
pubmed: 21131068
BMC Public Health. 2014 Jun 09;14:575
pubmed: 24912531
PLoS One. 2014 Jun 05;9(6):e97832
pubmed: 24902041
Arch Gerontol Geriatr. 2018 Nov - Dec;79:32-38
pubmed: 30086414
J Clin Epidemiol. 2008 Nov;61(11):1104-12
pubmed: 18538993
PLoS One. 2013 Sep 17;8(9):e74176
pubmed: 24069278
Geriatr Gerontol Int. 2015 Jan;15(1):1-10
pubmed: 25163532
Soc Psychiatry Psychiatr Epidemiol. 2016 Oct;51(10):1449-1455
pubmed: 27539269
Maturitas. 2018 Jan;107:84-91
pubmed: 29169587
Eur J Epidemiol. 2017 Feb;32(2):159-163
pubmed: 27999971
Maturitas. 2018 Mar;109:53-62
pubmed: 29452782
BMJ Open. 2020 Aug 20;10(8):e035392
pubmed: 32819936
PLoS One. 2017 Sep 14;12(9):e0183966
pubmed: 28910309
Clin Interv Aging. 2019 Dec 20;14:2273-2280
pubmed: 31908437
Arch Gerontol Geriatr. 2017 Jan - Feb;68:62-67
pubmed: 27654809
J Gerontol A Biol Sci Med Sci. 2020 Sep 25;75(10):1974-1980
pubmed: 31406983
Popul Health Manag. 2019 Apr;22(2):127-137
pubmed: 30096023
Geriatr Gerontol Int. 2019 Nov;19(11):1157-1164
pubmed: 31529597
Kidney Int. 2018 Mar;93(3):545-559
pubmed: 29398134
J Gerontol A Biol Sci Med Sci. 2011 Mar;66(3):301-11
pubmed: 21112963
BMJ. 2015 Jan 20;350:h176
pubmed: 25646760
BMJ Open. 2019 Jun 9;9(6):e028333
pubmed: 31182451
Public Health. 2015 Nov;129(11):1539-46
pubmed: 26210070
Fam Pract. 2016 Feb;33(1):61-8
pubmed: 26567547
PLoS One. 2010 Dec 29;5(12):e15941
pubmed: 21209965
Qual Life Res. 2015 Apr;24(4):909-18
pubmed: 25344816
J Clin Epidemiol. 1998 May;51(5):367-75
pubmed: 9619963
BMC Geriatr. 2018 Jun 25;18(1):147
pubmed: 29940868
Ann Fam Med. 2012 Mar-Apr;10(2):142-51
pubmed: 22412006
Soc Sci Med. 1996 Jan;42(2):257-64
pubmed: 8928034
Health Qual Life Outcomes. 2019 Jun 24;17(1):107
pubmed: 31234889
PLoS One. 2015 Sep 22;10(9):e0138521
pubmed: 26394368
J Gen Intern Med. 2016 Apr;31(4):380-6
pubmed: 26432693
BMJ Open. 2017 Mar 8;7(3):e013529
pubmed: 28274966
Int J Equity Health. 2017 May 15;16(1):79
pubmed: 28506233
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Mar 10;40(3):277-283
pubmed: 30884604
BMC Health Serv Res. 2014 Oct 02;14:451
pubmed: 25274447
Int J Cardiol. 2014 Dec 15;177(2):477-82
pubmed: 25443249
JAMA Intern Med. 2018 Mar 1;178(3):363-372
pubmed: 29379964
BMC Med. 2014 Oct 23;12:188
pubmed: 25338506
BMC Health Serv Res. 2010 May 06;10:111
pubmed: 20459621
Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S459-S465
pubmed: 28395951
PLoS One. 2015 Jul 08;10(7):e0127199
pubmed: 26154083
J Gerontol A Biol Sci Med Sci. 2016 Feb;71(2):205-14
pubmed: 26419978
Epilepsy Behav. 2020 Feb;103(Pt B):106453
pubmed: 31427266
Ann Fam Med. 2015 Sep;13(5):446-50
pubmed: 26371265
Geriatr Gerontol Int. 2018 Oct;18(10):1447-1452
pubmed: 30178629
BMC Neurol. 2020 Nov 27;20(1):431
pubmed: 33243167
Int J Environ Res Public Health. 2020 May 11;17(9):
pubmed: 32403412
J Comorb. 2019 Aug 22;9:2235042X19870934
pubmed: 31489279
BMC Geriatr. 2019 Jul 27;19(1):198
pubmed: 31351469
Vasa. 2020 Mar;49(2):85-86
pubmed: 32091976
BMJ Open. 2015 Oct 07;5(10):e007235
pubmed: 26446164
Lancet. 2013 Nov 2;382(9903):1525-33
pubmed: 24152939
BMJ Open. 2014 Jul 11;4(7):e004694
pubmed: 25015470
Health Qual Life Outcomes. 2017 Apr 17;15(1):73
pubmed: 28412945
Curr Diab Rep. 2018 Oct 8;18(11):125
pubmed: 30294763
BMJ Open. 2019 Aug 18;9(8):e024268
pubmed: 31427309
BMC Med. 2015 Aug 03;13:178
pubmed: 26239481
BMC Fam Pract. 2015 Oct 14;16:129
pubmed: 26462820
J Hypertens. 2019 Sep;37(9):1822-1831
pubmed: 31368919
JAMA. 2015 Jul 7;314(1):52-60
pubmed: 26151266
Prev Chronic Dis. 2014 Oct 23;11:E187
pubmed: 25340359
BMJ Open. 2019 Jan 25;9(1):e023927
pubmed: 30782718
BMC Public Health. 2008 Apr 14;8:119
pubmed: 18410677
PLoS One. 2014 Jul 21;9(7):e102149
pubmed: 25048354
BMC Public Health. 2013 Mar 21;13:251
pubmed: 23517342